1,25-dihydroxyvitamin D3 modulates the effects of interleukin 2 independent of IL-2 receptor binding
- 1 February 1990
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 125 (2) , 396-414
- https://doi.org/10.1016/0008-8749(90)90094-8
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Transpleural gradient of 1,25-dihydroxyvitamin D in tuberculous pleuritis.Journal of Clinical Investigation, 1989
- 1,25‐Dihydroxyvitamin D3 POtentiates the in vitro inhibitory effects of cyclosporin A on T cells from rheumatoid arthritis patientsArthritis & Rheumatism, 1989
- Analysis of prostaglandin E2 effect on T lymphocyte activation. Abrogation of prostaglandin E2 inhibitory effect by the tumor promotor 12.0 tetradecanoyl phorbol-13 acetate.Journal of Clinical Investigation, 1987
- Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA.Journal of Clinical Investigation, 1987
- γ-interferon stimulates production of 1,25-dihydroxyvitamin D3 by normal human macrophagesBiochemical and Biophysical Research Communications, 1985
- Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol).Journal of Clinical Investigation, 1984
- 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells.Journal of Clinical Investigation, 1984
- Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis.Journal of Clinical Investigation, 1983
- Hypercalcemia in an Anephric Patient with Sarcoidosis: Evidence for Extrarenal Generation of 1,25-Dihydroxyvitamin DNew England Journal of Medicine, 1981
- Rapid multiparameter analysis of cell stimulation in mixed lymphocyte culture reactions.Journal of Histochemistry & Cytochemistry, 1977